Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00612989
What this trial is testing

Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

Who this might be right for
GlioblastomaGliosarcoma
Duke University 42
Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University
Early research (Phase 1)Active Not RecruitingNCT00268385
What this trial is testing

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Not Yet RecruitingNCT07791264
What this trial is testing

FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+1 more
City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)UnknownNCT03463733
What this trial is testing

Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)

Who this might be right for
GliomaGlioblastoma
M.E. van Linde 54
Very early researchUnknownNCT04417933
What this trial is testing

Tumor Electric Fields Treatment System for Glioblastoma

Who this might be right for
Glioblastoma
Xiangya Hospital of Central South University 5
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Early research (Phase 1)Looking for participantsNCT07579208
What this trial is testing

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

Who this might be right for
Phase 1NK CellIL13Ra+4 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Very early researchStudy completedNCT02207010
What this trial is testing

AZD1775 in Recurrent GBM Patients

Who this might be right for
GlioblastomaGBM
St. Joseph's Hospital and Medical Center, Phoenix 20
Testing effectiveness (Phase 2)Study completedNCT03034135
What this trial is testing

Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Cantex Pharmaceuticals 23
Early research (Phase 1)Looking for participantsNCT05769660
What this trial is testing

Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
BeyondBio Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00301418
What this trial is testing

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 11
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Early research (Phase 1)Ended earlyNCT00006247
What this trial is testing

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 33
Early research (Phase 1)Looking for participantsNCT07551336
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
Malignant GliomaHigh-Grade GliomasGlioblastoma+2 more
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00039364
What this trial is testing

Imatinib Mesylate in Treating Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 112
Testing effectiveness (Phase 2)Looking for participantsNCT02394626
What this trial is testing

Surgery for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Insel Gruppe AG, University Hospital Bern 120
Large-scale testing (Phase 3)Study completedNCT00078988
What this trial is testing

High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 1
Next Page